We distill cutting-edge medical technologies to their essence, then re-invent them as affordable, reliable, easy-to-use tools that work in places where resources are limited, power is scarce, or trained health care workers are few and far between.
A new initiative led by PATH in partnership with John Snow, Inc., the DMPA-SC Access Collaborative works with ministries of health and partners to strengthen scale-up and build a robust global market for DMPA-SC as an important addition to the full range of contraceptive options.
Several thousands of health workers around the world have been trained to safely provide DMPA-SC injections in clinics, community locations, and villages, and even to support women to self-inject.
Family planning leaders can draw from an established base of evidence to integrate DMPA-SC in efforts to address unmet need and increase access to contraception through a range of delivery channels.
Research in Uganda and elsewhere has shown that women are able to self-administer DMPA-SC safely and effectively, that they like doing so, and that self-injection helps support women to continue using injectable contraception.
What happened at the global challenge to complete the design of the RELI pump.
Vaccine vial monitors are small stickers with a big impact: alerting health workers to heat-damaged vaccines before they are accidentally used.